NCT05980871View on ClinicalTrials.gov

Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Early Syphilis
Interventions
DRUG

Doxycycline

doxycycline (100 mg orally twice daily for 7 days)

DRUG

Ceftriaxone

Ceftriaxone (1g intramuscularly once)

DRUG

benzathine penicillin G

benzathine penicillin G (2.4 MU intramuscularly once)

Trial Locations (1)

110

Kuan-Yin Lin, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER